Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 16 | 16 |
| Marketable Securities | 60 | 0 | 0 |
| Receivables | 2,980 | 2,637 | 2,637 |
| Inventories | 2,040 | 1,982 | 1,982 |
| Other current assets | 600 | 1,179 | 1,179 |
| TOTAL | $5,680 | $5,813 | $5,813 |
| Non-Current Assets | |||
| PPE Net | 0 | 2,183 | 2,183 |
| Other Non-Current Assets | 60 | 59 | 59 |
| TOTAL | $60 | $2,241 | $2,241 |
| Total Assets | $7,600 | $8,054 | $8,054 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 60 | 534 | 534 |
| Accounts payable and accrued liabilities | 0 | 1,485 | 1,485 |
| Accrued Expenses | 0 | 1,345 | 1,345 |
| Other current liabilities | 850 | 1,077 | 1,077 |
| TOTAL | $4,520 | $6,470 | $6,470 |
| Non-Current Liabilities | |||
| Long Term Debt | 2,030 | 746 | 746 |
| TOTAL | $2,030 | $746 | $746 |
| Total Liabilities | $6,550 | $7,217 | $7,217 |
| Shareholders' Equity | |||
| Common Shares | 2 | 3 | 3 |
| Retained earnings | 1,050 | 835 | 835 |
| Other shareholders' equity | -2 | 0 | 0 |
| TOTAL | $1,050 | $838 | $838 |
| Total Liabilities And Equity | $7,600 | $8,054 | $8,054 |